Peer-reviewed AEYE-DS trials show high sensitivity, specificity and imageability, testing whether autonomous retinal AI can expand diabetes screening.
FDA clears Emboline’s Emboliner for embolic protection during TAVR, opening a U.S. launch after head-to-head testing against Sentinel.
Nutromics gains FDA Breakthrough Device status for its continuous vancomycin monitoring patch, but clinical validation remains the decisive test.
LUMA Vision has secured additional FDA clearance for VERAFEYE, integrating real-time 2D and 3D cardiac anatomy, catheter tracking and procedural guidance ahead of a planned 2027 U.S. launch.
Cleveland Clinic has completed the first human implantation of Corcym’s TriMemo annuloplasty ring, moving a purpose-built Nitinol platform into tricuspid repair as cardiac surgery faces growing competition from transcatheter structural-heart therapies.
Abbott’s TactiFlex Duo combines pulsed field ablation and radiofrequency energy in one contact-force catheter, giving electrophysiologists a way to move between tissue-selective PFA and conventional thermal ablation without changing platforms during an AFib procedure.
Pivot has FDA-cleared software upgrades and national PBM access. Modular Medical now has to prove that simpler insulin delivery converts users.
Teleflex is highlighting BIONETIC-TRA data showing 100% procedural success with the Dynetic-35 stent through radial access in 25 patients with iliac artery disease.
Co-Diagnostics has completed the first international deployment of its Vector Smart mosquito surveillance platform, supplying an overseas U.S. Air Force base with local molecular testing and mosquito-abatement materials.
Sonorous Neurovascular has expanded its B-SILENT study into Toronto, testing the investigational BosSTENT in patients with severe pulse-synchronous tinnitus caused by cerebral venous sinus stenosis.